Prof. Dr. Burghardt Wittig

Chairman
Curriculum Vitae
Academic
current |
Chairman (Vorstand) Foundation Institute Molecular Biology and Bioinformatics, a non-profit foundation by Gentechnologiestiftung. |
2010-2017 |
Chairman (Vorstand) Foundation Institute Molecular Biology and Bioinformatics, a non-profit foundation by Mologen AG and Freie Universitaet Berlin. |
2003-2010 |
Director Institut fuer Molekularbiologie und Bioinformatik, Charité – Universitaetsmedizin Berlin (a Joint Institution of Freie Universitaet Berlin and Humboldt-Universitaet zu Berlin). |
1989-2003 |
Department Head of Molecular Biology AND Bioinformatics at Institut fuer Molekularbiologie Und Biochemie, Freie Universitaet Berlin. |
1990 |
Appointed Universitaetsprofessor (C4, German Full Professorship, tenure). |
1.4.1989 |
Awarded Schering Professur (S-C4, German Full Professorship), Foundation of Chair of Molecular Biology AND BioInformatics at Freie Universitaet Berlin. |
1989 |
Call to a Full Professorship (C4), tenure, by Freie Universitaet Berlin accepted. |
1988-89 |
Several calls to Full Professorship (C4), tenure, rejected. |
1987-89 |
Visiting Professor at Massachusetts Institute of Technology (MIT). Cooperation with Alexander Rich. |
1987 |
Awarded Extraordinary Professor. |
1986 |
Invitation by the Japanese Research Institution ERATO (Exploratory Research for Advanced Technology), Tokyo. Cooperation with Koki Horikoshi. |
1984-86 |
Visiting Professor at Massachusetts Institute of Technology (MIT). Cooperation with Alexander Rich and Alexander Varshavsky. |
1984 |
Invitation by the Weizmann Institute of Science, Rehovot. Cooperation with Edward Trifonov. |
1983-89 |
Heisenberg-Fellow of Deutsche Forschungsgemeinschaft. |
1983 |
Call to a Full Professorship (tenure) by Department of Biochemistry University of Cape Town rejected. |
1982 |
Offer of an Associate-Professorship at Freie Universitaet Berlin rejected. Acceptance of a Heisenberg-Fellowship from Deutsche Forschungsgemeinschaft. |
1980 |
Habilitation for "Biochemistry and Molecular Biology". |
1978 |
Appointed as Assistent Professor at Freie Universitaet Berlin. |
1976-78 |
Postdoc and head of a junior research group at Freie Universitaet Berlin. |
1976-86 |
Accompanying studies of physics (without academic degrees) as a guest student at Freie Universitaet Berlin (FUB), Technische Universitaet Berlin (TUB), California Institute of Technology (CalTech), and Massachusetts Institute of Technology (MIT). |
1976 |
Defense of thesis on "Purification and Characterization of the Four Lysine Specific Transfer-Ribonucleicacids from Chicken Embryos". |
1975 |
Final examination (Staatsexamen) as a physician for Human Medicine from Freie Universitaet Berlin. During medical studies experimental work for doctoral thesis at Institut fuer Molekularbiologie und Biochemie of Freie Universitaet Berlin and at Max-Planck-Institut fuer Molekulare Genetik in Berlin by supervision of H. Gottschling, V.A. Erdmann, O. Pongs, H.-J. Risse, H. Tiedemann, und H. G. Wittmann. |
1968 |
Enrollment as a medical student at Freie Universitaet Berlin. Education and diploma at German school of hearing aid technicians and work in parents business. Accompanying studies of physics (without academic degrees) at California Institute of Technology (CalTech). |
Business
current |
Senior Advisor to MOLOGEN AG |
2008-2014 |
Chairman of Scientific and Strategic Advisory Board of MOLOGEN AG. |
1998-2007 |
CEO of MOLOGEN AG (1998-2002 Mologen Holding AG). |
1998 |
Foundation of Mologen Holding AG in Berlin, Germany. Merger of Soft Gene GmbH and Mologen GmbH into Mologen Holding AG. IPO at German stock exchange June 1998. |
1997 |
Foundation of Mologen GmbH in Hamburg, Germany. |
1995 |
Organizer and scientific director of the treatment and research institution "Center for Somatic Gene Therapy". |
1989 |
Foundation of Soft Gene Entwicklungs- und Vertriebsgesellschaft für molekularbiologische Software mbH as a bioinformatic research spin-off. |
Potential Conflict of Interest
Prof. Wittig advises MOLOGEN AG against reimbursement of expenses. MOLOGEN Foundation Institute Molecular Biology and Bioinformatics receives funding by MOLOGEN AG.